Malin Corporation plc (MLC) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.008x

Based on the latest financial reports, Malin Corporation plc (MLC) has a cash flow conversion efficiency ratio of -0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-800.00K ≈ $-935.28K USD) by net assets (€96.20 Million ≈ $112.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Malin Corporation plc market capitalisation for the company's overall valuation and market capitalisation.

Malin Corporation plc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Malin Corporation plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Malin Corporation plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Malin Corporation plc ranked by their cash flow conversion efficiency. Explore Malin Corporation plc cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Royal Orchid Hotel (Thailand) Public Company Limited BK:ROH	-0.003x
Compa Sibiu RO:CMP	0.007x
HC Group Inc STU:HCI	0.125x
DPS Resources Bhd KLSE:7198	-0.015x
RATH Aktiengesellschaft VI:RAT	0.046x
Fundamental Global Inc. NASDAQ:FGNX	-0.010x
P&K Skin Research Center Co. Ltd KQ:347740	0.021x
Mural Oncology plc NASDAQ:MURA	-0.335x

Annual Cash Flow Conversion Efficiency for Malin Corporation plc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Malin Corporation plc from 2015 to 2024. View Malin Corporation plc stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€193.20 Million ≈ $225.87 Million	€-1.30 Million ≈ $-1.52 Million	-0.007x	+76.97%
2023-12-31	€109.50 Million ≈ $128.02 Million	€-3.20 Million ≈ $-3.74 Million	-0.029x	-14.91%
2022-12-31	€283.10 Million ≈ $330.97 Million	€-7.20 Million ≈ $-8.42 Million	-0.025x	-21.03%
2021-12-31	€218.90 Million ≈ $255.92 Million	€-4.60 Million ≈ $-5.38 Million	-0.021x	-103.21%
2020-12-31	€290.10 Million ≈ $339.16 Million	€-3.00 Million ≈ $-3.51 Million	-0.010x	+54.83%
2019-12-31	€179.10 Million ≈ $209.39 Million	€-4.10 Million ≈ $-4.79 Million	-0.023x	+70.89%
2018-12-31	€170.40 Million ≈ $199.22 Million	€-13.40 Million ≈ $-15.67 Million	-0.079x	+35.99%
2017-12-31	€221.40 Million ≈ $258.84 Million	€-27.20 Million ≈ $-31.80 Million	-0.123x	-68.98%
2016-12-31	€308.10 Million ≈ $360.20 Million	€-22.40 Million ≈ $-26.19 Million	-0.073x	-56.27%
2015-12-31	€365.40 Million ≈ $427.19 Million	€-17.00 Million ≈ $-19.87 Million	-0.047x	--

About Malin Corporation plc

IR:MLC Ireland Drug Manufacturers - Specialty & Generic

Market Cap

$35.40 Million

€30.28 Million EUR

Market Cap Rank

#23287 Global

#20 in Ireland

Share Price

€7.00

Change (1 day)

+0.00%

52-Week Range

€6.95 - €8.65

All Time High

€15.37